Guardant Health (GH) Change in Acquisitions & Divestments (2017 - 2026)

Guardant Health has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $954.9 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $954.9 million, up 210.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $647.6 million (up 110.73% YoY), and the FY2024 annual result was $35.0 million, up 2186.09% from the prior year.
• Change in Acquisitions & Divestments came in at $954.9 million for Q1 2026 at Guardant Health, up from -$307.3 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $954.9 million in Q1 2026 to a low of -$492.7 million in Q3 2023.
• The 5-year median for Change in Acquisitions & Divestments is $49.0 million (2022), against an average of $82.6 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 958.8% in 2023, while the deepest fall reached 882.06% in 2023.
• Guardant Health's Change in Acquisitions & Divestments stood at -$398.0 million in 2022, then surged by 100.38% to $1.5 million in 2023, then soared by 2186.09% to $35.0 million in 2024, then tumbled by 978.07% to -$307.3 million in 2025, then surged by 410.73% to $954.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $954.9 million (Q1 2026), -$307.3 million (Q3 2025), and $307.3 million (Q1 2025), per Business Quant data.